(Q36475981)

14 August 2017

1 reference

title

Prognostic factors for visual acuity improvement after intravitreal triamcinolone injection (English)

1 reference

14 August 2017

S Shulman

1

1 reference

14 August 2017

J R Ferencz

2

1 reference

14 August 2017

G Gilady

3

1 reference

14 August 2017

Y Ton

4

1 reference

14 August 2017

E Assia

5

1 reference

14 August 2017

publication date

12 May 2006

1 reference

14 August 2017

1 reference

14 August 2017

volume

21

1 reference

14 August 2017

issue

8

1 reference

14 August 2017

page(s)

1067-1070

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.eye.6702408

14 August 2017

exact match

0 references

cites work

Intravitreal triamcinolone improves vision in eyes with chronic diabetic macular oedema refractory to laser photocoagulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702408

Duration of the effect of intravitreal triamcinolone acetonide as treatment for diffuse diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702408

Intravitreal triamcinolone for the management of macular edema due to nonischemic central retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702408

Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702408

Intravitreal triamcinolone acetonide for the treatment of chronic pseudophakic cystoid macular oedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702408

Intravitreal triamcinolone acetonide for the treatment of cystoid macular edema secondary to Behçet disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702408

Intravitreal Triamcinolone for Radiation-Induced Macular Edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702408

Intravitreal triamcinolone acetonide for idiopathic cystoid macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702408

A randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration: one-year results

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702408

Infectious and presumed noninfectious endophthalmitis after intravitreal triamcinolone acetonide injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702408

Is diabetic retinopathy an inflammatory disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702408

Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702408

Nontuberculous mycobacterial endophthalmitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702408

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.EYE.6702408

1 reference

14 August 2017

1 reference